Skip to content
Open·Listed in the source's current feed today

DoW Breast Cancer, Clinical Research Extension Award

Defense Health Agency Contracting Activity - DHACA

Go to the official application

Want a reminder before this closes?

We'll email you 3 days before the deadline. One email, then we stop.

Free. Verify your email, then we send one reminder only.

Posted
Aug 20, 2026
Closes
Nov 18, 2026 (in 30 days)

See more open grant funding like this

Get alerted when new grant funding matching "breast cancer clinical" opens, nationwide.

Checking your account…

Free includes 1 alert. New listings reach free search, alerts and AI search after 10 days. Unsubscribe anytime.

Classification and identifiers

Solicitation number
HT942526BCRPCREA2
Assistance listing (CFDA)
12.420

Amount

Amount not listed here. Check the official program.

Who can apply

Open to all

About this opportunity

Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Clinical Research Extension Award supports research that extends the data collection, follow-up, and analysis of breast cancer clinical studies. The intent of this award mechanism is to increase the clinically relevant impact of breast cancer patient participation in clinical studies by addressing the knowledge lost due to early trial termination, limited patient follow-up, or suboptimal sample and/or data collection and analysis. All applications must address at least one of the FY26 BCRP overarching challenges or provide adequate justification for exception. Distinctive Features: • The research team must include two or more breast cancer consumer advocates. • This funding mechanism allows for a single Principal In...

Refine this search